Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics CorpUTHR · filed Oct 30, 2026

Accession no.
0001106578-26-000175
Filed
Oct 30, 2026, 4:30 PM ET
Trade date
Oct 29, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.65M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 29, 2026Common StockMOption exerciseAcquired+9,500$117.76+$1,118,720333,943Indirect
Oct 29, 2026Common StockSSaleDisposed−53$590.43F3−$31,292.77333,890Indirect
Oct 29, 2026Common StockSSaleDisposed−1,104$591.90F4−$653,459.81332,786Indirect
Oct 29, 2026Common StockSSaleDisposed−1,563$592.97F5−$926,809.92331,223Indirect
Oct 29, 2026Common StockSSaleDisposed−1,540$593.88F6−$914,574.28329,683Indirect
Oct 29, 2026Common StockSSaleDisposed−1,248$594.89F7−$742,428.59328,435Indirect
Oct 29, 2026Common StockSSaleDisposed−1,678$595.88F8−$999,885.63326,757Indirect
Oct 29, 2026Common StockSSaleDisposed−1,355$596.86F9−$808,746.38325,402Indirect
Oct 29, 2026Common StockSSaleDisposed−919$597.66F10−$549,245.13324,483Indirect
Oct 29, 2026Common StockSSaleDisposed−40$599.30−$23,972324,443Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 29, 2026Common StockMOption exerciseDisposed−9,500$0.00$0128,910Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $590.17 to $590.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $591.33 to $592.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $592.36 to $593.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $593.39 to $594.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $594.41 to $595.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $595.41 to $596.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $596.41 to $597.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $597.41 to $598.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)